1) Gleevec
格列卫
1.
Research of Gleevec on proliferation and angiogenesis of drug-resistant human ovarian carcinoma cell COC1;
格列卫对卵巢癌细胞COC1增殖及血管形成的影响
2.
Clinical observation of Gleevec combined with myeloablative allogeneic stem cells transplantation in treatment of chronic myeloid leukemia;
格列卫联合清髓性异基因造血干细胞移植治疗慢性髓性白血病
3.
Morphological evaluation of bone marrow during initial stage of Gleevec therapy for treatment of chronic myelogenous leukemia;
骨髓形态学评价在进展期慢性髓细胞白血病格列卫治疗初期的意义
2) Glivec
格列卫
1.
The Clinic Effect of Interrupting or Reducing the Use of Glivec on Gastrointestinal Stromal Tumor;
间断或减量应用格列卫治疗胃肠间质瘤对疗效的影响分析
2.
Effects of Glivec and hexamethylenebisacetamide on proliferation and apoptosis of K562 cells;
格列卫与六亚甲基二乙酰胺对K562细胞增殖和凋亡的影响
3) imatinib
格列卫
1.
Evidence-Based Treatment of a Patient with Chronic-Phase Chronic Myeloid Leukemia by Imatinib;
格列卫在1例慢性粒细胞白血病慢性期患者中的循证应用
2.
Objective To study the treatment and its possible mechanism of imatinib-induced severe fluid retention in chromic myeloid leukemia(CML).
目的探讨应用伊马替尼(格列卫)治疗慢性粒细胞白血病发生严重水潴留的处理及其可能的发生机制。
3.
Imatinib group rate of complete hematologic remission(CHR) 89.
目的:观察伊马替尼(格列卫)与异基因造血干细胞移植(Allo-SCT)在慢性粒细胞性白血病(CML)中的治疗情况。
4) Imatinib mesylate
格列卫
1.
Autogeneic peripheral blood hemopoietic stem cell transplantation for chronic myeloid leukemia with imatinib mesylate-induced negavitation of Philadelphia chromosome;
格列卫治疗慢性粒细胞白血病Ph染色体转阴后进行自体外周血干细胞移植的结果
2.
OBJECTIVE To study the effectiveness of arsenic trioxide(As_2O_3) combined with Imatinib mesylate in refractory chronic myelocytic leukemia,because Imatinib and As_2O_3 have different effective target and have no across tolerance.
目的通过As2O3联合格列卫对Bac/Abl的作用靶点及二者药物作用无交叉耐药性的机制,达到使两种药发挥协同作用,更有效地治疗难治性慢性粒细胞白血病的目的。
3.
Objective To explore the inhibitory mechanism of Imatinib mesylate on pulmonary fibrosis induced by bleomycin in mice.
目的探讨格列卫对小鼠肺纤维化的干预机制。
5) Gleevec(imatinib)
格列卫(伊马替尼)
6) K562/Glv cells
K562/Glv(耐格列卫的K562细胞)
补充资料：列卫
1.四周的防卫。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条